Partners

  Photogallery – NEW!

 

Registration On-line
Accommodation On-line
Tourist Program
Running at 2013 m

 Program

Program – new

 Posters

List of Posters
How to Prepare E-Poster

IMPORTANT INFORMATION FOR ALL POSTER PRESENTERS Please read carefully information regarding e-poster submission Deadline is May 15, 2013! Prepare your e-poster NOW
and it will be included in the "Helmut Vinazzer-Prize"
for the 2 best poster presentations!

The first one receiving
650 EUR
The second one receiving
350 EUR

Supported by:
AMGEN GmbH, Vienna, Austria

Helmuth-Vinazzer-Price for the best poster presentation. Supported by Amgen GmbH, Vienna, Austria www.amgen.at
AMGEN

Information for Partners & Exhibitors

First Announcement

Map

Silver Partners

Bayer Grifols Novo Nordisk Siemens

Bronze Partners

CSL Behring Glaxo GSK phizer Terumo

Partners

AOP Orphan Baxter Baxter Beckman Coulter Biogenix Boehringer Ingelheim Diagnostica Medista Octapharma Roche Werfen

Partner of E-Posters

Abbott lab.

Partner of Running on 2013 m

PRO.MED.CS

Medial Partners

Sestra ZDN ZVZ

Official Carrier

CSA

Abstracts

Call for Abstracts

The Scientific Committee invites all authors to submit their abstracts for consideration and inclusion in the Scientific Programme.

No on-line change is possible after the submission. Please check your abstract carefully before sending. If a change would be nevertheless needed, kindly contact the Scientific Secretariat malyjaro@fnhk.cz.

Please, read the instructions carefully prior to writing your abstract!

Abstracts not fulfilling the given instructions cannot be accepted!

The presenting author of a selected abstract commits himself/herself to attend the Congress and present the abstract in the session at the time decided by the Scientific Committee!

Deadlines

On-line Abstract submission is closed.

Abstracts submission deadline: February 15, 2013 (changed to March 1, 2013)
Abstract acceptance/rejection letter will be sent to authors by e-mail.

Abstract  Submission

Contribution Title

In block letters. Max. 20 words.

Name of the author(s)

First name initial(s) followed by the surname, names separated by commas. Max. 8 authors per abstract. Authors should omit degrees and titles and type in upper and lower case.

Address/Institution

Name of institution, city, state, country, no zip or postal code. If address is not the same for all authors, authors should give authors' correct affiliations by numbers.

Layout

Abstracts should be limited to 2000 characters body text (= without title, authors, and text). Cave: no figures, tables and images within abstract. Authors should not use any special formatting and should not include footnotes or references, as they will not be printed. If abstracts include special characters not normally found e.g. in the Times New Roman or Arial font, please provide a hard copy in addition to the electronic copy for comparison purposes. In particular, we are concerned about accent marks and mathematical symbols or Greek characters (e.g. Alpha, Beta).

Text of the abstract

The abstract should include:

Do not include footnotes or references in the abstract. Drug products should be identified by their non proprietary names only. Please avoid boldfacing, italics and underlining within the text.

Abbreviations

Standard abbreviations may be used. Give the term in full length when first mentioned, followed by the abbreviation in parenthesis.

Type of presentation

Please tick the appropriate box if you are an invited speaker, wish to present a poster or an oral.